- Filed
- Dec 6, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 30, 2024 | 41.7M sh |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $106.87M |
| Current Liabilities | Q3 2025 · Jan 31, 2024 | $82.98M |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $116.49M |
| Total Liabilities | Q3 2025 · Jan 31, 2024 | $97.78M |
| Current Assets | Q3 2025 · Oct 31, 2024 | $303.61M |
| Current Assets | Q3 2025 · Jan 31, 2024 | $280.16M |
| Total Assets | Q3 2025 · Oct 31, 2024 | $670.79M |
| Total Assets | Q3 2025 · Jan 31, 2024 | $657.66M |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 40.05M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 39.71M sh |
| Operating Cash Flow | Q3 2025 · Oct 31, 2023 | $23.06M |
| Cash And Equivalents | Q3 2025 · Oct 31, 2023 | $143.79M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2023 | $113.54M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $591.79M |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $602.32M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $606.19M |
| Stockholders Equity | Q3 2025 · Jan 31, 2023 | $606.09M |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | −$1.04 |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | −$2.74 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | −$1.04 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | −$2.74 |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $18.25M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $55.75M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $53.7M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $163.06M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$41.71M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$108.81M |
| Net Income | Q3 2025 · Jul 31, 2023 | −$31.2M |
| Net Income | Q3 2025 · Apr 30, 2023 | −$35.9M |
| Operating Income | Q3 2025 · Oct 31, 2023 | −$41.97M |
| Operating Income | Q3 2025 · Oct 31, 2023 | −$112.85M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $29.98M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $105.96M |
| Revenue | Q3 2025 · Oct 31, 2023 | $50.6M |
| Revenue | Q3 2025 · Oct 31, 2023 | $174.86M |